Chargement en cours...
Omacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemia
Chronic myelogenous leukemia (CML) is driven by the Bcr-Abl fusion protein which is a result of a (9;22) chromosomal translocation. Imatinib, dasatinib, and nilotinib (tyrosine kinase inhibitors, TKIs) have revolutionized how CML is treated. While the majority of patients respond to these kinase inh...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4048124/ https://ncbi.nlm.nih.gov/pubmed/24501394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-1283 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|